September 2025 Rewind: "Best of" Inside the ICE House
In September, Inside the ICE House aired ten new episodes, four traditional episodes, the new Biotech series, Markets in focus with Opening Bell Daily’s Phil Rosen and Inside the ICE House breakfast on the balcony.
Biotech Series Episode 1: Alto Neuroscience CEO Dr. Amit Etkin on the Next Chapt ...
September 2025 Rewind: "Best of" Inside the ICE House
In September, Inside the ICE House aired ten new episodes, four traditional episodes, the new Biotech series, Markets in focus with Opening Bell Daily’s Phil Rosen and Inside the ICE House breakfast on the balcony.
Biotech Series Episode 1: Alto Neuroscience CEO Dr. Amit Etkin on the Next Chapt ...
Episode 505: Episode 23-03 The Right Antidepressant the First Time?
On this week’s Tech Nation, developing antidepressants along with a test so when you take them, you know they will work. Dr. Amit Etkin, the founder and CEO Alto Neuroscience, explains how looking at each patient’s underlying biology is essential. Then Sir Rory Collins, the Principal Investigato ...
Video Episode 65 - Amit Etkin, Founder and CEO of Alto Neuroscience
With biotech, is it the destination, the journey, or both?
Find out in a new episode of the Biorasi Few & Far Between podcast. Host Chris O'Brien welcomes guest Amit Etkin, Founder and CEO of Alto Neuroscience and Professor of Psychiatry at Stanford University School of Medicine. We’ll be discu ...
Episode 539: Episode 23-37 The Right Antidepressant the First Time?
On this week’s Tech Nation, developing antidepressants along with a test so when you take them, you know they will work. Dr. Amit Etkin, the founder and CEO Alto Neuroscience, explains how looking at each patient’s underlying biology is essential. Then Sir Rory Collins, the Principal Investigato ...
Episode 505: Episode 23-03 The Right Antidepressant the First Time?
On this week’s Tech Nation, developing antidepressants along with a test so when you take them, you know they will work. Dr. Amit Etkin, the founder and CEO Alto Neuroscience, explains how looking at each patient’s underlying biology is essential. Then Sir Rory Collins, the Principal Investigato ...
A New Blueprint for Precision Psychiatry | $665m Alto Neuroscience CEO Dr. Amit Etkin
In this episode, I sit down with Dr. Amit Etkin, founder and CEO of Alto Neuroscience ($450m, NYSE: ANRO) and former tenured professor at Stanford, to explore the emerging field of precision psychiatry.
Instead of treating diagnoses as single diseases, Alto is using brain-based biomarkers, incl ...
Episode 134 - Amit Etkin - Founder & CEO Alto Neuroscience
In this episode of The BioHub Podcast, Max sits down with Amit Etkin, Founder and CEO of Alto Neuroscience.
Psychiatry is one of the few areas in medicine still dominated by trial and error.
Amit is trying to change that.
A trained psychiatrist and neuroscientist, Amit founded Alto to bring p ...
Amit Etkin: Precision Psychiatry’s Future Isn’t Genomics—It’s Brain Activity
For decades, psychiatry has relied on symptom-based diagnosis and trial-and-error treatment, but precision medicine is set to transform mental health care by using objective biological measures—such as EEG, sleep and circadian rhythm data, and cognitive testing—with AI-driven analysis to match p ...
HCW 2026: Two key recent papers have validated the use of pramipexole in depression - Alto Neuro believes it has a combination therapy that can make it more tolerable and therefore even better
Founder and CEO Amit Etkin describes the independent academic work that has been published on this and explains how ALTO-207, which is a combination of pramipexole and ondansetron, appears to have a more tolerable profile. Plus, an update on two other key programs
ENJIN PENCARIAN PODCAST
Anda boleh menggunakan tapak web kami untuk mencari podcast3,821,058dan episod195,323,021mengikut orang, tempat atau topik.
If I have seen further than others, it is by listening to podcasts and standing upon the shoulders of
giants.
‐ Isaac "Llamacorn" Newton
SUNTING
Terima kasih kerana membantu memastikan pangkalan data podcast dalam keadaan terkini.
